TrianglePUBLICATIONS · 34554208
Final Overall Survival Efficacy Results of Ivosidenib for Patients With Advanced Cholangiocarcinoma With IDH1 Mutation: The Phase 3 Randomized Clinical ClarIDHy Trial.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- JAMA Oncol
- Publication date
- 2021 Nov 1
- First author
- Zhu AX
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Zhu AX
- type
- Author
- name
- Macarulla T
- type
- Author
- name
- Javle MM
- type
- Author
- name
- Kelley RK
- type
- Author
- name
- Lubner SJ
- type
- Author
- name
- Adeva J
- type
- Author
- name
- Cleary JM
- type
- Author
- name
- Catenacci DVT
- type
- Author
- name
- Borad MJ
- type
- Author
- name
- Bridgewater JA
- type
- Author
- name
- Harris WP
- type
- Author
- name
- Murphy AG
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Zhu AX
- type
- Author
- name
- Macarulla T
- type
- Author
- name
- Javle MM
- type
- Author
- name
- Kelley RK
- type
- Author
- name
- Lubner SJ
- type
- Author
- name
- Adeva J
- type
- Author
- name
- Cleary JM
- type
- Author
- name
- Catenacci DVT
- type
- Author
- name
- Borad MJ
- type
- Author
- name
- Bridgewater JA
- type
- Author
- name
- Harris WP
- type
- Author
- name
- Murphy AG
- type
- Author
- bibliography ids
- nci-bib-0169caae8fcc24807f3dc921
- book metadata
- content sha256
- f1ba2df33aa0ab2ffbb8d1011d812cd923ec08dfe665090e8a604be2a981118c
- document type
- citation
- dois
- 10.1001/jamaoncol.2021.3836
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:34554208
- immutable id
- pubmed:34554208@f1ba2df33aa0ab2ffbb8d1011d812cd923ec08dfe665090e8a604be2a981118c
- journal
- abbreviation
- JAMA Oncol
- issn electronic
- 2374-2445
- issn print
- 2374-2437
- issue
- 11
- name
- JAMA oncology
- nlm unique id
- 101652861
- pages
- 1669-1677
- volume
- 7
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 34554208
- provenance
- batch id
- 192b6392c165c6b06274
- provider
- NCBI PubMed ESummary
- record sha256
- f1512c644644f4c6748f5b449ebbb57365b5ee8af7263db048d848f7c4383c0e
- response sha256
- 7d81e9fb11ee99e6ad4116aecd61ba71cd6bf76f2a8f8f6d15c5c85e9c6c56b4
- retrieved at
- 2026-09-09T23:48:02.713075+00:00
- publication date
- display
- 2021 Nov 1
- precision
- day
- year
- 2021
- publication types
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Final Overall Survival Efficacy Results of Ivosidenib for Patients With Advanced Cholangiocarcinoma With IDH1 Mutation: The Phase 3 Randomized Clinical ClarIDHy Trial.
Preserved source evidence · Not medical advice